Companies: 10,795·Total market cap: $144.5T
Juva Life Inc.

Juva Life Inc.

JUVAFOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$164
P/E Ratio
52W High$0.0012
52W Low$0.000001

Juva Life Inc. (JUVAF) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

juvaf · pe ratio · data through Dec 31, 2022

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for Juva Life Inc. (JUVAF) measures how much investors pay for each dollar of the company's trailing earnings. JUVAF's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$0.06.

N/A
P/E Ratio (TTM)N/A — Company is not profitable (TTM)

Source: FMP · /ratios-ttm · /analyst-estimates · 2022-12-31

Forward P/E
N/A
EPS (TTM)
-$0.06
TTM · diluted EPS
PEG Ratio
-0.00
Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Juva Life Inc. SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-09

PE Ratio History

2018 – 2022 · Annual
PE Ratio (TTM)
EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

PE Ratio vs Peers

Drug Manufacturers - Specialty & Generic · 6 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
Juva Life Inc.
Juva Life Inc.You
JUVAF
$0MN/A-$0.06
Aoxing Pharmaceutical Company, Inc.
Aoxing Pharmaceutical Company, Inc.
AOXG
$0M51.76x$0.00
Aequus Pharmaceuticals Inc.
Aequus Pharmaceuticals Inc.
AQSZF
$0MN/A-$0.02
CBD Life Sciences Inc.
CBD Life Sciences Inc.
CBDL
$0MN/A-$0.00
Golden Developing Solutions, Inc.
Golden Developing Solutions, Inc.
DVLP
$0MN/A-$0.00
Grapefruit USA, Inc.
Grapefruit USA, Inc.
GPFT
$1MN/A-$0.00
Hemp Naturals, Inc.
Hemp Naturals, Inc.
HPMM
$0MN/A-$0.01

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 5 of 5 years
Fiscal Year EndPE RatioEPS (TTM)YoY ChangePE vs Max
2022-12-31Latest
FY2022
$-0.06
2021-12-31
FY2021
$-0.07
2020-12-31
FY2020
$-0.13
2019-12-31
FY2019
$-0.07
2018-12-31
FY2018
$-0.04

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for Juva Life Inc. (JUVAF) measures how much investors pay for each dollar of the company's trailing earnings. JUVAF's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$0.06.

PE Ratio = Stock Price ÷ EPS (TTM)
= $0.00 ÷ -$0.06 = N/A
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Frequently asked questions

JUVAF pe ratio · 6 questions

JUVAF's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.00 and TTM EPS of -$0.06. Data sourced from Financial Modeling Prep via JUVAF's SEC 10-K and 10-Q filings.

JUVAF PE ratioWhat is JUVAF PE ratioCurrent PE ratio of JUVAFJUVAF PE ratio today

Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Juva Life Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09